Effect of Ultrasound-guided Corticosteroid Injection Versus Palpation-guided Injection for de Quervain's Disease

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 8, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

December 31, 2022

Conditions
De Quervain Disease
Interventions
PROCEDURE

US-guided injection

For US-guided injection, a 22 MHZ linear array probe (Esaote MyLab™ClassC, Italy) will be used for guidance of injection via a transverse scan, in-plane approach. After sterilization, the probe will be placed at the radial styloid with maximal swelling or tenderness. Then a 2.5 cm 25-gauge needle will be placed into the tendon sheath via transverse scan, in-the-plane approach, and the injectate will be pushed into the tendon sheath. Care will be taken avoiding injury of vessels and the superficial branch of radial nerve during the injection.

PROCEDURE

palpation-guided injection

Injectate: a mixture of 10mg triamcinolone acetonide (10mg/1ml) and 0.3ml 1% lidocaine. For palpation-guided injection, a 2.5cm 25-gauge needle will be inserted almost horizontally between APL and EPB tendons, just distal to the radial styloid, at the site of maximum tenderness. Then the mixture of triamcinolone and lidocaine will be pushed into the common tendon sheath.

Trial Locations (1)

Unknown

Shin Kong Wu Ho-Su Memorial Hospital, Taipei

All Listed Sponsors
lead

Shin Kong Wu Ho-Su Memorial Hospital

OTHER

NCT04260984 - Effect of Ultrasound-guided Corticosteroid Injection Versus Palpation-guided Injection for de Quervain's Disease | Biotech Hunter | Biotech Hunter